Timothy K. Andrews - Net Worth and Insider Trading
Timothy K. Andrews Net Worth
The estimated net worth of Timothy K. Andrews is at least $7 dollars as of 2024-11-05. Timothy K. Andrews is the General Counsel & Secretary of Sienna Biopharmaceuticals Inc and owns about 66,737 shares of Sienna Biopharmaceuticals Inc (SNNAQ) stock worth over $7. Details can be seen in Timothy K. Andrews's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy K. Andrews has not made any transactions after 2017-08-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Timothy K. Andrews
Timothy K. Andrews Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy K. Andrews owns 2 companies in total, including Sienna Biopharmaceuticals Inc (SNNAQ) , and Prometheus Biosciences Inc (RXDX) .
Click here to see the complete history of Timothy K. Andrews’s form 4 insider trades.
Insider Ownership Summary of Timothy K. Andrews
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNNAQ | Sienna Biopharmaceuticals Inc | 2019-08-06 | General Counsel & Secretary |
| RXDX | Prometheus Biosciences Inc | 2021-03-11 | General Counsel |
Timothy K. Andrews Latest Holdings Summary
Timothy K. Andrews currently owns a total of 1 stock. Timothy K. Andrews owns 66,737 shares of Sienna Biopharmaceuticals Inc (SNNAQ) as of August 1, 2017, with a value of $7.
Latest Holdings of Timothy K. Andrews
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNNAQ | Sienna Biopharmaceuticals Inc | 2017-08-01 | 66,737 | 0.00 | 7 |
Holding Weightings of Timothy K. Andrews
Timothy K. Andrews Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy K. Andrews has made a total of 0 transactions in Sienna Biopharmaceuticals Inc (SNNAQ) over the past 5 years. The most-recent trade in Sienna Biopharmaceuticals Inc is the acquisition of 15,000 shares on August 1, 2017, which cost Timothy K. Andrews around $225,000.
Insider Trading History of Timothy K. Andrews
- 1
Timothy K. Andrews Trading Performance
GuruFocus tracks the stock performance after each of Timothy K. Andrews's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy K. Andrews is -3.77%. GuruFocus also compares Timothy K. Andrews's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy K. Andrews within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy K. Andrews's insider trading performs compared to the benchmark.
Performance of Timothy K. Andrews
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.66 | | | | | |
| Relative Return to S&P 500(%) | 18.65 | | | | | |
Timothy K. Andrews Ownership Network
Ownership Network List of Timothy K. Andrews
Ownership Network Relation of Timothy K. Andrews
Timothy K. Andrews Owned Company Details
What does Sienna Biopharmaceuticals Inc do?
Who are the key executives at Sienna Biopharmaceuticals Inc?
Timothy K. Andrews is the General Counsel & Secretary of Sienna Biopharmaceuticals Inc. Other key executives at Sienna Biopharmaceuticals Inc include Chief Financial Officer Alexander Azoy , Chief Medical Officer Paul F. Lizzul , and director & President & CEO Iii Frederick Beddingfield .
Sienna Biopharmaceuticals Inc (SNNAQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sienna Biopharmaceuticals Inc Insider Transactions
Timothy K. Andrews Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy K. Andrews. You might contact Timothy K. Andrews via mailing address: 30699 Russell Ranch Road, Suite 140, Westlake Village Ca 91362.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
